课题基金 / 基金详情

Models and Gene Therapies for AAT Deficiency

Models and Gene Therapies for AAT Deficiency
AAT 缺乏症的模型和基因疗法
批准号：
10463803
负责人：
Terence R. Flotte
金额：
$8.38万
依托单位：
UNIV OF MASSACHUSETTS MED SCH WORCESTER
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
项目状态：
未结题
起止时间：
2021-08-09 至 2026-07-31
来源：
https://reporter.nih.gov/project-details/10463803
关键词：
AccountingBudgetsCommunicationCommunication ResearchComplexConsultationsEnsureFacultyFeedbackGoalsGrantHuman ResourcesInstitutesIowaMassachusettsModelingOccupational activity of managing financesPersonsProgress ReportsResearchResearch PersonnelScheduleScientistStructureTimeUniversitiesWorkalpha 1-Antitrypsin Deficiencydata exchangegene therapymedical schoolsmeetingsmemberprogramstherapeutic RNAvirtual

项目摘要

项目成果

Terence R. Flotte的其他基金

相似基金

相关文献

中文摘要
翻译
管理核心 项目摘要 行政核心将为管理这方面的财务问题提供一个结构。 复杂的多组件程序并创建用于通信的工具 调查人员领导着每一个组成部分。行政核心还将召集内部 和外部顾问委员会成员，作为客观但知情的科学家提供 向P01调查人员反馈每个组件的优点和缺点 并评估随着时间的推移每个组件(以及整个计划)的进度。
英文摘要
Administrative Core Project Summary The administrative core will provide a structure for management of the financial aspects of this complex multi-component program and create vehicle for communication among the investigators leading each component. The administrative core will also convene both internal and external advisory board members, as objective but informed scientists to provide feedback to the P01 investigators about the strengths and weaknesses of each component and to evaluate the progress of each component (and of the overall program) over time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Models and Gene Therapies for AAT Deficiency
Models and Gene Therapies for AAT Deficiency
Optimized Gene Replacement for AAT deficiency and Modeling of Clinical Outcomes in small and large animal models
Optimized Gene Replacement for AAT deficiency and Modeling of Clinical Outcomes in small and large animal models
海外基金